It is highly expressed on cytotoxic lymphocytes in the TME of liver, ovarian and bladder cancer, and the expression of NKG2A on tumour-infiltrating lymphocytes has been associated with poor prognosis in various cancer types [93–96]. Here, KLRC1 is linked to cancer.